RE:RE:RE:RE:VolumeThis looks like the beginning of a little bit of increase in the SP I wanted to see. If it can reach 3.50-4.00$ range before any news, it would be a good sign. Again, I don't think it has anything to do with Trogarzo IV push. I think it is anticipation of some good news in cancer. Again, they specified "business update" in the Q3 CC for a reason. Also, remember that it is open label trial, as we saw with Juniper, relatives of single patients are aware of what is going on for them. Also, if they really have something, it could be hard for insiders at Thera to totally hide it. I am not saying they revealed any inside info to anybody, but just the tone of a conversation can be somewhat revealing. We'll see. I am not expecting spectacular news, but at least something positive on efficacy.